Optic Nerve Neoplasms - Etiology
Research News and Information

Sunday, November 22, 2009

Primary optic nerve tumours.

30 Jan 2009 PURPOSE OF REVIEW: Advances have been made in the treatment of primary optic nerve tumours. With a focus on the last few years' publications, recommendations for clinical management are being developed. RECENT FINDINGS: In low-grade optic nerve ... Read more...

Ocular clusterin expression in von Hippel-Lindau disease.

13 Nov 2007 PURPOSE: Clusterin is a multifunctional glycoprotein. Its mRNA is ubiquitously expressed, with high levels in von Hippel-Lindau (VHL) target organs such as the brain, liver, kidney, and adrenal medulla. Decreased clusterin secretion has been ... Read more...

Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.

30 May 2007 PURPOSE: Neurofibromatosis type 1 (NF-1) is an autosomal dominant phakomatosis with a prevalence of 1 in 2000 to 1 in 5000. Up to 24% of these patients have optic pathway gliomas (OPGs). In the present study, the use of sweep visual evoked ... Read more...

Latest indexed articles for 'Optic Nerve Neoplasms - Etiology'

These are the very latest articles for this heading:

• Primary optic nerve tumours. 30 Jan 2009
• Ocular clusterin expression in von Hippel-Lindau disease. 13 Nov 2007
• Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials. 30 May 2007
• Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. 27 Feb 2007
• Optic nerve sheath meningioma: current diagnosis and treatment. 30 Dec 2006
• Neuroophthalmological management of optic pathway gliomas. 30 Dec 2006
• Case reports of three patients showing optic nerve head melanocytoma and systemic hypertension. 30 Dec 2006
• Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? 30 Jul 2006
• [Chiasmatic cavernoma] 30 Mar 2005
• Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations. 30 Dec 2004
• Ophthalmological manifestations in segmental neurofibromatosis type 1. 30 Oct 2004
• [A case of von Hippel-Lindau disease with papillary capillary hemangioma treated by photodynamic therapy] 30 Mar 2004
• Growth and pubertal disorders in neurofibromatosis type 1. 27 Feb 2003
• Optic nerve glioma in a patient with von Hippel-Lindau syndrome. 30 Dec 2002
• Patients with persistent pain after enucleation studied by MRI dynamic color mapping and histopathology. 30 Aug 2001
• T-cell lymphoproliferative disorder of vitreous associated with mycosis fungoides. 30 Jan 2000
• A prospective 10 year follow up study of patients with neurofibromatosis type 1. 29 Apr 1998
• Anterior visual pathway gliomas. 30 Dec 1996
• Melanocytomas of the optic nerve and uvea. 30 Dec 1996

See a longer list of these articles.

Technical information about 'Optic Nerve Neoplasms'

Definition: Benign and malignant neoplasms that arise from the optic nerve or its sheath. OPTIC NERVE GLIOMA is the most common histologic type. Optic nerve neoplasms tend to cause unilateral visual loss and an afferent pupillary defect and may spread via neural pathways to the brain.

Descriptor UI: D019574

Alternative terms: Optic Nerve Neoplasms; Neoplasm, Optic Nerve; Optic Nerve Neoplasm; Neoplasms, Optic Nerve; Optic Nerve Sheath Neoplasm; Optic Nerve Sheath Tumors; Malignant Optic Nerve Neoplasm; Tumor, Optic Nerve, Malignant; Tumor, Malignant, Optic Nerve; Malignant Optic Nerve Tumor; Optic Nerve Tumor, Malignant; Malignant Optic Nerve Sheath Neoplasms; Optic Nerve Sheath Neoplasms, Malignant; Optic Nerve Sheath Tumors, Malignant; Malignant Optic Nerve Sheath Tumors; Benign Optic Nerve Neoplasm; Neoplasm, Benign, Optic Nerve; Tumor, Optic Nerve, Benign; Optic Nerve Neoplasm, Benign; Tumor, Benign, Optic Nerve; Benign Optic Nerve Tumor; Neoplasm, Optic Nerve, Benign; Benign Optic Nerve Sheath Neoplasms; Optic Nerve Sheath Tumors, Benign; Benign Optic Nerve Sheath Tumors;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.588.614.300.600; C04.588.614.596.240.240; C10.292.225.800; C10.292.700.500; C10.551.360.500; C11.640.544;

History Note: 98

Technical Notes: coordinate IM with histologic type of neoplasm (IM)